X-136209986-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001159699.2(FHL1):c.852G>C(p.Gln284His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000165 in 1,209,089 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001159699.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FHL1 | NM_001159699.2 | c.852G>C | p.Gln284His | missense_variant | 6/6 | ENST00000370683.6 | NP_001153171.1 | |
FHL1 | NM_001159702.3 | c.*32G>C | 3_prime_UTR_variant | 8/8 | ENST00000394155.8 | NP_001153174.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FHL1 | ENST00000370683.6 | c.852G>C | p.Gln284His | missense_variant | 6/6 | 1 | NM_001159699.2 | ENSP00000359717.1 | ||
FHL1 | ENST00000394155.8 | c.*32G>C | 3_prime_UTR_variant | 8/8 | 5 | NM_001159702.3 | ENSP00000377710.2 |
Frequencies
GnomAD3 genomes AF: 0.00000902 AC: 1AN: 110846Hom.: 0 Cov.: 22 AF XY: 0.0000303 AC XY: 1AN XY: 33034
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183531Hom.: 0 AF XY: 0.0000294 AC XY: 2AN XY: 67959
GnomAD4 exome AF: 9.11e-7 AC: 1AN: 1098243Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 363597
GnomAD4 genome AF: 0.00000902 AC: 1AN: 110846Hom.: 0 Cov.: 22 AF XY: 0.0000303 AC XY: 1AN XY: 33034
ClinVar
Submissions by phenotype
X-linked myopathy with postural muscle atrophy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 13, 2024 | This sequence change replaces glutamine, which is neutral and polar, with histidine, which is basic and polar, at codon 268 of the FHL1 protein (p.Gln268His). This variant is present in population databases (no rsID available, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with FHL1-related conditions. ClinVar contains an entry for this variant (Variation ID: 537349). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Aug 17, 2022 | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 21, 2022 | The p.Q268H variant (also known as c.804G>C), located in coding exon 5 of the FHL1 gene, results from a G to C substitution at nucleotide position 804. The glutamine at codon 268 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at